Pooled platelet concentrates provide a small benefit over single-donor platelets for patients with platelet refractoriness of any etiology

Background At our institution, patients with platelet refractoriness (of any etiology) are sometimes switched from apheresis platelets to pooled platelets before human leukocyte antigen (HLA)-matched units become available. Study design and methods Seven patients were analyzed. Platelet counts were...

Full description

Bibliographic Details
Main Authors: Ying-Hsia Chu, William Nicholas Rose, William Nawrot, Thomas J. Raife
Format: Article
Language:English
Published: SAGE Publishing 2021-05-01
Series:Journal of International Medical Research
Online Access:https://doi.org/10.1177/03000605211016748